The Supreme Court has closed the contempt case against Swami Ramdev and Acharya Balakrishna, the Managing Director of Patanjali Ayurved, regarding misleading advertisements.

The Supreme Court of India has directed Patanjali Ayurved to submit an affidavit confirming whether its request to remove misleading advertisements from social media platforms has been fulfilled.

In a recent development, the Supreme Court has chastised the Uttarakhand State Licensing Authority for its inaction regarding misleading advertisements by Patanjali Ayurved Limited.

AstraZeneca, a prominent player in the global COVID-19 vaccine landscape, has made a significant legal acknowledgment regarding its vaccine's potential side effects.

In a recent development, the Supreme Court has taken significant steps to address the issue of misleading advertisements, particularly focusing on protecting the interests of consumers.

Ramdev and Balakrishna submitted an unconditional apology before the Supreme Court on April 9, acknowledging the gravity of their actions. However, the Supreme Court was left unimpressed.

Patanjali Ayurved Limited's managing director, Acharya Balkrishna, has issued an unconditional apology for his company's misleading claims regarding the miraculous properties of its formulations.

The apex court criticised Patanjali for disseminating 'misleading' adverts and prohibited the company from advertising any products related to diseases or medical conditions.